Nutsa Burduli

Artiklar

Journal article: HELIYON. 2024;10(15):e34976
NK cell line modified to express a potent, DR5 specific variant of TRAIL, show enhanced cytotoxicity in ovarian cancer models
Sheedy AM; Burduli N; Prakash A; Gurney M; Hanley S; Prendeville H; Sarkar S; O'Dwyer J; O'Dwyer M; Dolan EB
Article: SCIENCE TRANSLATIONAL MEDICINE. 2024;16(747):eadi2952
Tumor-associated NK cells drive MDSC-mediated tumor immune tolerance through the IL-6/STAT3 axis
Neo SY; Tong L; Chong J; Liu Y; Jing X; Oliveira MMS; Chen Y; Chen Z; Lee K; Burduli N; Chen X; Gao J; Ma R; Lim JP; Huo J; Xu S; Alici E; Wickstrom SL; Haglund F; Hartman J; Wagner AK; Cao Y; Kiessling R; Lam KP; Westerberg LS; Lundqvist A
Article: JOURNAL OF EXPERIMENTAL AND CLINICAL CANCER RESEARCH. 2024;43(1):13
Natural killer cells drive 4-1BBL positive uveal melanoma towards EMT and metastatic disease
Neo SY; Oliveira MMS; Tong L; Chen Y; Chen Z; Cismas S; Burduli N; Malmerfelt A; Teo JKH; Lam K-P; Alici E; Girnita L; Wagner AK; Westerberg LS; Lundqvist A
Article: JOURNAL FOR IMMUNOTHERAPY OF CANCER. 2022;10(10):e005308
Tumor MHC class I expression alters cancer-associated myelopoiesis driven by host NK cells
Neo SY; Jing X; Tong L; Tong D; Gao J; Chen Z; De Los Santos MC; Burduli N; Ferreira SDS; Wagner AK; Alici E; Rolny C; Cao Y; Lundqvist A

Meeting abstract: BLOOD. 2019;134:5536
Targeting CD38^high Acute Myeloid Leukaemia with "Affinity Optimized" Chimeric Antigen Receptor and Membrane Bound TRAIL Expressing Natural Killer Cells
Nolan E; Stikvoort A; Gurney M; Burduli N; Kirkham-McCarthy L; Daly J; Van de Donk NWCJ; Mutis T; Sarkar S; O'Dwyer ME

Master of Science, Cancer research, Development of genetically engineered Natural Killer cells for the treatment of Pancreatic Cancer, Medicine, National University of Ireland, Galway, 2019
Bachelor of Science, Biochemistry, Mutation of a key enzyme residue in MSH3 subunit of MutSβ to inactivate its enzymatic function, Biological and Chemical Sciences, National University of Ireland, Galway, 2015